Abstract:OBJECTIVE:To explore the risks of long-term proton pump inhibitors (PPI) use.METHODS:A total of 79 study subjects were selected from patients seeking health care at outpatient gastroenterology clinic at Peking University People's Hospital during January 2011 to June 2013. Long-term PPI use was defined as taking PPI for at least one year. They were divided into study (n = 79) and control (n = 47) groups after matching for age and gender. The study group had 43 females and 36 males with an average age of (63 ± 10) years. And the control group had 28 females and 19 males with an average age of (63 ± 9) years. Data collected were demographic characteristics, clinical diagnosis, detailed dosing information of PPI. serum hemochrome, serum gastrin, vitamin B(12), serum iron, magnesium, calcium, copper, zinc, bone density of hip joint and lumbar vertebra L(1-4). Statistic analysis was performed with SPSS software (t and χ(2) test).RESULTS:The medium duration of PPI use was 3.07(1-15) years. Daily usage was a full or half amount of pharmaceutical directed dosage. Questionnaires regarding appetite, defecation, infection, otalgia change in long-term PPI use indicated:among them, 77(97.5%) cases had no appetite change and 2 (2.5%) improved. And 73 cases (92.4%) had no change or 2 cases improved (2.5%) in bowel movements habits while another 4 cases (5.1%) changed into loose stools. Lung or intestinal infection was not found. No case had an onset of otalgia related with PPI intake. Among PPI users, 14 cases (17.7%) appeared to have gastric polyps. T value of total bone density of hip and inter-hip was -0.93 ± 1.04 and -0.61 ± 0.91 respectively in the study group. And both were lower than those in the control group (-0.44 ± 1.12, -0.19 ± 0.94; t = -2.49, -2.35; P = 0.014, 0.021). No statistical differences existed in T value of neck of hip, as well as total T value and T value of each L(1-4) between study and control groups (all P > 0.05). Higher serum Mg compared to control group ((1.03 ± 0.08) vs (0.97 ± 0.07) mmol/L, t = 4.13, P = 0.000). No difference of serum calcium, copper, iron, zinc, vitamin B(12), folic acid and Hb,MCV,MCH between study and control groups (all P > 0.05). Higher serum gastrin versus normal range and controls were found in the study group ((108 ± 28) vs 100 vs (79 ± 26) ng/L, t = 2.56, 5.78; both P < 0.05). Taking manual routine dosage have higher hip and lumbar osteoporosis than half-dosage, and bone density decreased and normal bone density ratios are lower(all P < 0.05).CONCLUSIONS:Long-term use of PPI with small or average dosage may slightly decrease hip density and increase serum gastrin. However, there is little effect on vitamin B(12) and minerals.

Analysis on The Use of Oral Proton Pump Inhibitors in The Inpatients of Peking University Shenzhen Hospital During 2009-2011

Retrospective Comments on Prescriptions of Oral Proton Pump Inhibitors for Outpatients in A General Hospital

Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China:a multicentre cross-sectional study

Drug Utilization Study of Three Intestinal Cleaning Agents in a General Hospital

Effectiveness of Continuous Improvement by a Clinical Pharmacist-Led Guidance Team on the Prophylactic Antibiotics Usage Rationality in Intervention Procedure at a Chinese Tertiary Teaching Hospital

Effect of Omeprazole in treating peptic ulcers of children

Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments

Optimization of Hospital Drug Management Model under the Supervision of Internet Plus Medical Health

Clinical Application of Proton Pump Inhibitors

Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China

Rationale use of proton pump inhibitors: Observational study of hospital based prescriptions and role of clinical pharmacist

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Research Progress and Clinical Use of Proton Pump Inhibitors

Meta-analysis of proton pump inhibitor for preventing recurrence of non-steroidal anti-inflammatory drags-induced ulcers

[The Risks of Long-Term Proton Pump Inhibitors Use].

An Analysis of the Utilization of Cephalosporins from 2007 to 2011 in Guangdong Province of China.

Evidence-based evaluation of proton pump inhibitors off-label use

Standardized evaluation about single-disease clinical pathway on perioperative use of proton pump inhibitors in a grade 2 and first-class hospital

Cost-effective Analysis of Proton Pump Inhibitors in Long-term Management of Gastroesophageal Reflux Disease: A Narrative Review

Impact of Interventions Targeting the Inappropriate Use of Proton‐pump Inhibitors by Clinical Pharmacists in a Hepatobiliary Surgery Department

Utilization of Anti-infective Agents in Both the Outpatients and the Inpatients of Our Hospital During 2007-2009 Period